Skip to content Skip to footer

2026

Conference Publication

Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

Wu, Rodger, Ghali, Mark, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Lynch, Kate D., Wark, Gabrielle, Haifer, Craig, Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Lawrance, Ian C., Verdon, Christine, Ghaly, Simon, Andrews, Jane and Connor, Susan J. (2026). Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)03029-5

Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

2026

Conference Publication

536 Upadacitinib vs corticosteroid for the management of ulcerative colitis flares: a multicentre prospective study

Gilmore, Robert, An, Yoon-Kyo and Begun, Jakob (2026). 536 Upadacitinib vs corticosteroid for the management of ulcerative colitis flares: a multicentre prospective study. Digestive Disease Week (DDW) 2026, Chicago, IL United States, 2-5 May 2026. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5107(26)02287-x

536 Upadacitinib vs corticosteroid for the management of ulcerative colitis flares: a multicentre prospective study

2026

Conference Publication

Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

Riley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)02786-1

Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

2026

Conference Publication

TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN'S DISEASE COHORT: INSIGHTS FROM THE CROHN'S COLITIS CURE DATA INSIGHTS PROGRAM

Riley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN'S DISEASE COHORT: INSIGHTS FROM THE CROHN'S COLITIS CURE DATA INSIGHTS PROGRAM. Digestive Disease Week (DDW), Chicago Il, May 02-05, 2026. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN'S DISEASE COHORT: INSIGHTS FROM THE CROHN'S COLITIS CURE DATA INSIGHTS PROGRAM

2026

Conference Publication

Sa1578 Divided by distance: insights into regional disparities in inflammatory bowel disease care across Australia from the Crohn’s colitis cure data insights program

Wu, Rodger, Caquilpan, Victor, Wilson, William E., Lynch, Kate D., Ng, Watson, Lawrance, Ian C., Radford-Smith, Graham, Walker, Gareth, Begun, Jakob, Moore, Gregory, Ghaly, Simon, Dutt, Shoma, Giles, Edward, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-992. doi: 10.1016/s0016-5107(26)02519-8

Sa1578 Divided by distance: insights into regional disparities in inflammatory bowel disease care across Australia from the Crohn’s colitis cure data insights program

2026

Conference Publication

Mo1590 Prescribing patterns and persistence of advanced therapies in people with ulcerative colitis who are bio-experienced: Crohn’s colitis cure data insights program

Wu, Rodger, Ghali, Mark, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Lynch, Kate D., Wark, Gabrielle, Haifer, Craig, Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Lawrance, Ian C., Verdon, Christine, Ghaly, Simon, Andrews, Jane and Connor, Susan J. (2026). Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1201. doi: 10.1016/s0016-5107(26)02960-3

Mo1590 Prescribing patterns and persistence of advanced therapies in people with ulcerative colitis who are bio-experienced: Crohn’s colitis cure data insights program

2026

Conference Publication

Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

Ghali, Mark, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Haifer, Craig, Ng, Watson, Lynch, Kate D., Lawrance, Ian C., Begun, Jakob, Walker, Gareth, Radford-Smith, Graham, Shahzad, Asif, Boyapati, Ray, Verdon, Christine, Connor, Susan J., Andrews, Jane and Ghaly, Simon (2026). Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)03036-2

Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

2026

Journal Article

Extended high‐dose tofacitinib induction improves clinical response in ulcerative colitis: a multicenter cohort study

Gilmore, R., Pham, T., Fernandes, R. G., Wright, E. K., Lo, S., Rosella, O., De Cruz, P., Andrew, B., Vasudevan, A., Gazelakis, K., Moore, G. T., Thin, L., Au, K., Ghaly, S., Chen, C., Mohsen, W., Goodwin, T., Sparrow, M. P., Ward, M. G., Chew, M., Garg, M., Shelton, E., Lawrance, I. C., Thorat, A., da Fonseca Pereira, C., Begun, J. and An, Y. K. (2026). Extended high‐dose tofacitinib induction improves clinical response in ulcerative colitis: a multicenter cohort study. JGH Open, 10 (5) e70410, 5. doi: 10.1002/jgh3.70410

Extended high‐dose tofacitinib induction improves clinical response in ulcerative colitis: a multicenter cohort study

2026

Conference Publication

Su1577 Real-world trends in subcutaneous and intravenous infliximab and vedolizumab use in inflammatory bowel disease from 2021 to 2024: Insights from Crohn’s colitis cure data insights program

Wu, Rodger, Su, Wai Kin, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Wark, Gabrielle, Lawrance, Ian C., Begun, Jakob, Haifer, Craig, Radford-Smith, Graham, Walker, Gareth, Shahzad, Asif, Giles, Edward, Dutt, Shoma, Connor, Susan J. and Andrews, Jane (2026). Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1081. doi: 10.1016/s0016-5107(26)02715-x

Su1577 Real-world trends in subcutaneous and intravenous infliximab and vedolizumab use in inflammatory bowel disease from 2021 to 2024: Insights from Crohn’s colitis cure data insights program

2026

Conference Publication

Su1579 Timing and predictors of bowel resection in a large Crohn’s disease cohort: Insights from the Crohn’s colitis cure data insights program

Riley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1082. doi: 10.1016/s0016-5107(26)02717-3

Su1579 Timing and predictors of bowel resection in a large Crohn’s disease cohort: Insights from the Crohn’s colitis cure data insights program

2026

Conference Publication

Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

Wu, Rodger, Caquilpan, Victor, Wilson, William E., Lynch, Kate D., Ng, Watson, Lawrance, Ian C., Radford-Smith, Graham, Walker, Gareth, Begun, Jakob, Moore, Gregory, Ghaly, Simon, Dutt, Shoma, Giles, Edward, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)02588-6

Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

2026

Conference Publication

Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

Wu, Rodger, Su, Wai Kin, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Wark, Gabrielle, Lawrance, Ian C., Begun, Jakob, Haifer, Craig, Radford-Smith, Graham, Walker, Gareth, Shahzad, Asif, Giles, Edward, Dutt, Shoma, Connor, Susan J. and Andrews, Jane (2026). Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)02784-8

Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM

2026

Journal Article

Development of a novel polyleucine-based immunopotentiator for subunit vaccines against Group A Streptococcus

Lu, Lantian, Cruz, Jazmina L. Gonzalez, Giri, Rabina, Zhang, Yuexiao, Bashiri, Sahra, Cadena, Leslie C. Domínguez, Li, Shuhang, Khalil, Zeinab G., Hussein, Waleed M., Wang, Jingwen, Kiong, Jolynn, Lu, Xuehan, Zhang, Jiahui, Lu, Miao, Huang, Wenbin, Kong, Wei Yang, Nahar, Ummey Jannatun, Koirala, Prashamsa, Guo, Zhong, Walden, Patricia, Blumenthal, Antje, Begun, Jakob, Alexandrov, Kirill, Toth, Istvan, Stephenson, Rachel J. and Skwarczynski, Mariusz (2026). Development of a novel polyleucine-based immunopotentiator for subunit vaccines against Group A Streptococcus. Small, 22 (22) e11459, 1-20. doi: 10.1002/smll.202511459

Development of a novel polyleucine-based immunopotentiator for subunit vaccines against Group A Streptococcus

2026

Journal Article

Advances in Crohn's disease: A comprehensive review of pathophysiology, diagnosis, and emerging therapeutics

An, Yoon‐Kyo, Gilmore, Robert, Radford‐Smith, Graham and Begun, Jakob (2026). Advances in Crohn's disease: A comprehensive review of pathophysiology, diagnosis, and emerging therapeutics. JGH Open, 10 (4) e70394, 1-13. doi: 10.1002/jgh3.70394

Advances in Crohn's disease: A comprehensive review of pathophysiology, diagnosis, and emerging therapeutics

2026

Conference Publication

In young people with inflammatory bowel disease, does 904nm laser photobiomodulation influence the gut microbiome?

Laakso, E-Liisa, Ewais, Tatjana, Hunt, Matthew, Murtaza, Nida and Begun, Jakob (2026). In young people with inflammatory bowel disease, does 904nm laser photobiomodulation influence the gut microbiome?. Mechanisms of Photobiomodulation Therapy XX, San Francisco, CA United States, 17-23 January 2026. Bellingham, WA United States: SPIE. doi: 10.1117/12.3078349

In young people with inflammatory bowel disease, does 904nm laser photobiomodulation influence the gut microbiome?

2026

Journal Article

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial

Jairath, Vipul, Vuyyuru, Sudheer K, Zou, Guangyong, Ma, Christopher, Neustifter, Blue, Agboton, Christian, Romo Bautista, Itzel, Allocca, Mariangela, An, Yoon-Kyo, Begun, Jakob, Bryant, Robert V, Danese, Silvio, Dubinsky, Marla, Feagan, Brian G, Freire, Marcelo, Novak, Kerri L, Panaccione, Remo, Pudipeddi, Aviv, Rubin, David T, Sands, Bruce E, Sparrow, Miles P, Taylor, Stuart A, Gecse, Krisztina B, Wilkens, Rune and Maaser, Christian (2026). Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial. BMJ Open Gastroenterology, 13 (1) e002088, 1-13. doi: 10.1136/bmjgast-2025-002088

Evaluating treatment to a target of transmural healing in patients with moderately to severely active Crohn’s disease: rationale, design and protocol for the randomised controlled VECTORS trial

2026

Conference Publication

Development of a next generation engineered live microbiome biotherapeutic, E. coli Nissle 1917-TTR, for ulcerative colitis.

Horgan, Kevin, Barnett, Jacqueline, Godovannyi, Artem, Usakiewicz, Jacek, Adur, Malavika, Mayer, Emeran, Begun, Jakob and Gibson, Deanna (2026). DEVELOPMENT OF A NEXT GENERATION ENGINEERED LIVE MICROBIOME BIOTHERAPEUTIC, E COLI NISSLE 1917-TTR, FOR ULCERATIVE COLITIS. Crohn's and Colitis Congress, Las Vegas Nv, Jan 22-24, 2026. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Development of a next generation engineered live microbiome biotherapeutic, E. coli Nissle 1917-TTR, for ulcerative colitis.

2026

Conference Publication

Development of a next generation engineered live microbiome biotherapeutic, E. coli Nissle 1917-TTR, for ulcerative colitis

Horgan, Kevin, Barnett, Jacqueline, Godovannyi, Artem, Usakiewicz, Jacek, Adur, Malavika, Mayer, Emeran, Begun, Jakob and Gibson, Deanna (2026). DEVELOPMENT OF A NEXT GENERATION ENGINEERED LIVE MICROBIOME BIOTHERAPEUTIC, E COLI NISSLE 1917-TTR, FOR ULCERATIVE COLITIS. Inflammatory Bowel Diseases, 32 (Supplement_1) izag006.006, 32. doi: 10.1093/ibd/izag006.006

Development of a next generation engineered live microbiome biotherapeutic, E. coli Nissle 1917-TTR, for ulcerative colitis

2026

Journal Article

Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists

Chen, Lynna, Ruddick-Collins, Leonie, An, Yoon-Kyo, Baraty, Brandon, Begun, Jakob, Boyapati, Ray K., Bryant, Robert V., Smith, Rebecca L. and Srinivasan, Ashish R. (2026). Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists. Therapeutic Advances in Gastroenterology, 19 17562848261432538, 1-11. doi: 10.1177/17562848261432538

Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists

2026

Conference Publication

Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists

Chen, L., Ruddick-Collins, L., An, Y. K., Baraty, B., Begun, J., Boyapati, R. K., Bryant, R., Smith, R. and Srinivasan, A. (2026). Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists. 21st Congress of ECCO, Stockholm, Sweden, 18-21 February 2026. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjaf231.587

Examining attitudes to intestinal ultrasound in inflammatory bowel disease: a national survey of Australian gastroenterologists